Should we screen for and treat childhood dyslipidaemia?BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a886 (Published 23 July 2008) Cite this as: BMJ 2008;337:a886
- Douglas Kamerow, chief scientist, RTI International, and associate editor, BMJ
It’s not an accident that evidence based guidelines more or less began with clinical preventive services. Unlike treatment for problems that produce symptoms, preventive medicine is optional. We have the luxury of time to gather and evaluate the evidence for the efficacy and even effectiveness of screening tests and counselling. When someone rushes into your surgery bleeding or doubled over in pain, it would hardly be acceptable to send them away untreated to await the results of a randomised controlled trial for their problem. But that is just what we do when people want to know whether they should undergo computed tomography to screen for lung cancer or be given vitamins to prevent heart disease. “Sorry,” we say, “insufficient evidence.”
And this is even truer for children—at least when the question is whether to screen them for early signs or symptoms of adult diseases. Firstly, we need to know whether the problem will even persist into adulthood. Secondly, do we have a safe and effective treatment? And most importantly, does treating the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial